US$ 28.29
fda approved glp-1 receptor agonists Patient education tips for GLP-1, weight loss drug treatment Exploration of the potential association
Description
15: 297302 [DOI] [PubMed] [Google Scholar] 140.Usdin TB, Mezey E, Button DC, et al

Informed consent was not requested, in agreement with the Swedish legislation for conducting registry studies

Inhibition of dipeptidyl peptidase-4 impairs ventricular function and promotes cardiac fibrosis in high fat-fed diabetic mice

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Initially developed for the management of T2DM, GLP-1 receptor agonists exert multiple metabolic effects, including improved insulin sensitivity, appetite suppression, and weight reduction

K., Zinman, B., Choi, H., Connelly, P
